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Abstract
Background: Measles virus (MV) is a member of the Paramyxoviridae family and an important human pathogen causing
strong immunosuppression in affected individuals and a considerable number of deaths worldwide. Currently, measles is a
re-emerging disease in developed countries. MV is usually quantified in infectious units as determined by limiting dilution
and counting of plaque forming unit either directly (PFU method) or indirectly from random distribution in microwells
(TCID50 method). Both methods are time-consuming (up to several days), cumbersome and, in the case of the PFU assay,
possibly operator dependent.
Methods/Findings: A rapid, optimized, accurate, and reliable technique for titration of measles virus was developed based
on the detection of virus infected cells by flow cytometry, single round of infection and titer calculation according to the
Poisson’s law. The kinetics follow up of the number of infected cells after infection with serial dilutions of a virus allowed
estimation of the duration of the replication cycle, and consequently, the optimal infection time. The assay was set up to
quantify measles virus, vesicular stomatitis virus (VSV), and human immunodeficiency virus type 1 (HIV-1) using antibody
labeling of viral glycoprotein, virus encoded fluorescent reporter protein and an inducible fluorescent-reporter cell line,
respectively.
Conclusion: Overall, performing the assay takes only 24–30 hours for MV strains, 12 hours for VSV, and 52 hours for HIV-1.
The step-by-step procedure we have set up can be, in principle, applicable to accurately quantify any virus including
lentiviral vectors, provided that a virus encoded gene product can be detected by flow cytometry.
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Introduction
Determining the amount of infectious virus is a crucial issue for
any virologist. To date, different methods have been used for viral
titration depending on the virus concerned. The most popular
ones are the plaque forming units (PFU) [1] and the 50% tissue
culture infective dose (TCID50) [2]. They are used for cytopathic
viruses (e.g. HIV-1, poliovirus, Japanese encephalitis virus, measles
virus, etc…) and are based on serial dilutions of the virus-
containing samples and observation of the appearance of a
cytopathic effect (CPE) in a cell monolayer. The PFU technique
measures the number of virus particles capable of forming plaques
per volume unit, and accounts for the replication potency of the
virions, i.e. it is a functional measure. The PFU assay is laborious,
poorly automatable, and requires several hours to several days
according to the speed of virus growth and propagation. It also
suffers from subjectivity because of the tedious manual plaque
counting and possible plaque-like defects in the cell monolayer.
The TCID50 method is a statistical derivative of the PFU assay.
Instead of counting individual plaques, multiple replicates of each
virus dilution are made and the TCID50 titer is calculated from
the 50% endpoint where half of the replicates contained at least
one PFU. Wells with destroyed cell monolayers are easily counted
either manually under the microscope or automatically using a
viable colorimetric assay. TCID50 values are intrinsically
discontinuous, and the value coverage is non-homogeneous (i.e.
intervals between two discontinuous values are not identical) as
illustrated in Figure 1. Therefore, increasing the measurement
accuracy would require a number of replicates high enough to
discourage routine usage. Handling and time requirements of
TCID50 and PFU methods are comparable. With both assays,
virus titration is more difficult with cells growing in suspension.
Due to the inconveniences mentioned above for these two
titration methods, novel, quicker and less cumbersome techniques
have been developed. Such titration procedures have been
developed for influenza viruses, adenoviruses, HIV-1, SV40,
human coronaviruses, hepatitis A virus, as well as for recombinant
and/or virus-like particles [3–13]. Many of these techniques are
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using immunodetection of viral proteins (structural or glycopro-
teins) by flow cytometry [9],[7],[13–14]. In such studies, the virus
titer is calculated from the proportion of infected cells (i.e.
positively labeled) after exposure of a given number of indicator
cells to a given virus suspension volume. In each case, the
assumption is made that one cell is infected by a single infectious
virus particle. However, at a too high multiplicity of infection
(MOI) (i.e. the ratio of infectious virus particle per cell) such an
assumption becomes erroneous, leading to an underestimation of
virus titers. Indeed, the higher the MOI, the higher the probability
of multiple viruses infecting a single cell. Likewise, secondary
infections of cells by newly produced viruses during the assay lead
to overestimation of the virus titer.
To avoid these pitfalls, we have explored the prerequisites and
limitations of the use of flow cytometry for virus quantification
with a specific focus on measles virus (MV) strains, while taking
into account the following parameters: (i) virus infected cells must
be clearly distinguished from the uninfected ones by emitting a
fluorescent signal above the autofluorescence background; (ii) the
virus titer is best determined by averaging titers calculated from
several amounts of the viral inoculum; (iii) the measurement
should be optimally done at, or just prior to, the completion of the
first viral replication cycle to avoid secondary infection; (iv) virus
titer should be calculated from the number of uninfected cells by
applying the Poisson probability distribution and (v) the method
should be validated by comparison with an already existing
titration technique e.g. TCID50. In addition, the assay could be
used to approximate the duration of a single replication cycle. Our
method was validated by the strong correlation found with the
TCID50 technique over a large set of samples. The assay lasts less
than two days which favorably compares with the ,1–2 week
duration of the conventional PFU or TCID50 methods currently
used for MV titration.
In order to validate this rapid assay for measles virus titration,
we have compared it to the classical TCID50 method. A high
amount of virus samples quantified by both techniques showed a
strong correlation indicating thus the accuracy of the novel
method. The detection limit is 10
4 infectious units/ml.
To illustrate its wide application, our method was also adapted
to titrate recombinant MV and vesicular stomatitis virus (VSV)
expressing the green fluorescent protein (GFP) as gene reporter of
the infection. Likewise, the method was also applicable to measure
HIV-1 titer using a reporter cell line that conditionally expresses
GFP under the control of the Tat-inducible HIV-1 LTR
promoter. In the latter case, titer accuracy required the blocking
of cell growth by the DNA polymerase inhibitor aphidicolin over
the 2-day measurement period.
Materials and Methods
MV titration by TCID50
We have used TCID50 titration method as a reference for the
validation of our rapid titration technique. TCID50 is based on
the end-point dilution of the virus at which a cytopathic effect
(CPE) is detected in 50% of the cell culture replicates infected by a
given amount of virus suspension [2]. The latter was serially
diluted in 0.25 ml of DMEM medium supplemented with 6% fetal
calf serum (FCS) and antibiotics (culture medium) by serial transfer
of 0.027 ml (i.e. ten-fold dilution) in the first row of a 96 well plate.
When diluting the virus suspension, each micropipette tip ought to
be changed at every dilution to avoid uneven distribution of
Figure 1. Virus titration by TCID50 is intrinsically discontinuous. Discontinuous titer values given by all possible combinations of percentage
of infected wells above, at, and below 50% of eight replicates within one Log range. Note that (i) some mantissa are identical for two or four
combinations (indicated in italics in x axis) and (ii) identical sets of mantissa of the logarithm are obtained at any place below and above the displayed
titer range. Vertical bars indicate the variable interval separating one titer value from its nearest superior and inferior titer value.
doi:10.1371/journal.pone.0024135.g001
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0.030 ml of each dilution was distributed vertically, i.e. 8 replicates
for each dilution. Permissive cells, i.e. Vero cells, (10,000 cells in
0.2 ml) were seeded in each well, and incubated at 37uCi n5 %
C02 and humid atmosphere. CPE induced by measles virus could
be observed under the microscope after 3–4 days, but because
CPE located in the well edge could hardly be spotted, the final
counting of wells with CPE was done after 10 days. This
incubation time can be much shorter for quicker growing viruses
(i.e. 1–2 days for VSV). To avoid underestimation of virus titer, the
incubation time should be adapted to the virus species and
physicochemical conditions used for virus propagation. TCID50
was then calculated using the formula:
Log TCID50 ½  =ml~Log }Above 50%} dilution ½ 
z }Above 50%} value{0:5 ðÞ = }Above 50%} value{ ð
Below 50% valueÞzLog 1=v ½ 
where ‘‘Above 50%’’ dilution is the last dilution expressed as the
denominator of 1 (i.e. 250 for 1/250 dilution) for which $50%
wells display CPE, (‘‘Above 50%’’ and ‘‘Below 50%’’ values are
fraction of wells with CPE at the last dilution for which $50%
wells display CPE and fraction of wells with CPE at the next
dilution, respectively, and v the virus volume (in ml) from the
undiluted sample used to inoculate the wells.
Step-by-step MV titration procedure by flow cytometry
(protocol at a glance)
The flow cytometry titration method, based on the immuno-
detection of the viral F-glycoprotein on the surface of infected cells,
was performed as shown below (an example of an assay timing is
indicated when taking into account the following parameters: (i)
titration of ,20 samples of an MV strain with (ii) a replication
cycle of 18 hours, (iii) without interruption of the assay until the
calculation of the titer is done using the online spreadsheet).
1. Start - cell seeding (10h00). Seed 100 000 of Vero cells
for MV laboratory/vaccine strains or Vero-Slam cells for MV -
wild type strains in 0.25 ml of culture medium in each well of a 48
well plate. Preferably, plate the cells in the morning and infect
them in the afternoon. Alternatively, inoculate the cells just after
seeding. In that case perform the seed and inoculation in the
afternoon. Do not seed the cells the day prior to the inoculation
because of resulting change in cell number due to cell growth. The
cell number seeded should be carefully adjusted since it is part of
the formulae to calculate the virus titer in IU/ml (see below).
Likewise, during the assay, cell growth should be very limited
hence cell plating and infection on the same day. Indeed any
overgrowth of uninfected cells versus infected cells during the titer
assay will result in the underestimation of the virus titer (see also
the application for titration of HIV-1 below).
2. Virus inoculation (16h00). Prepare and add three-fold
dilutions of the virus suspension to the cells in duplicate (see
Figure 2 for a ‘‘protocol at a glance’’). Fix the inoculation volume
Figure 2. Experimental scheme and data analysis for virus titration based on flow cytometry numbering of infected cells –
‘‘Protocol at a glance’’. Top panel from right to left, 3-fold dilution of unknown virus sample. Middle panel, example of histogram profiles of
infected cells according to the virus inoculum size. Bottom panel: % of infected cells as graphically determined and equation used to calculate the
titer for each inoculum volume. Underlined in grey, selected values for titer determination by averaging.
doi:10.1371/journal.pone.0024135.g002
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the inoculation volume up to 0.090 or 0.27 ml of undiluted virus
with complete replacement of the cell supernatant (0.25 ml) to
avoid volume enlargement.
3. Place the cells into an incubator at 376C with 5% of CO2
supply (17h00). Do not replace the culture cell medium.
4. Flow cytometry: labeling (Day+1 10h00; time=24 h). Op-
tion 1 - for MV vaccine and laboratory strains (i.e. Schwarz, Edmonston, Halle).
N At 18 h post inoculation (next morning), discard the
supernatant;
N Add 0.07 ml of trypsin to each well;
N Incubate for ,5 minutes;
N add 0.2 ml of ‘‘wash medium’’ - DMEM supplemented with
6% FCS and 0.05% NaN3 (this medium blocks the trypsin and
prevents any internalization of cell surface proteins, and should
be used throughout the labeling procedure);
N Detach the cells by pipetting and individually transfer the cell
suspensions into a V-bottom (or U-bottom) 96 well plate (when
only a small number of samples and serial dilutions are carried
on the procedure can be done in 1.5 ml conical tubes);
N Shortly centrifuge (3–5 min, 4006g, 4uC) the plate, carefully
discard the supernatant to avoid any loss of cell pellet;
N Add 0.05 ml of anti-F monoclonal antibody optimally diluted
in ‘‘wash medium’’ and resuspend the cells by pipetting;
N Incubate the plate for 30 min at 4uC;
N Wash the cells once by adding 0.25 ml of medium and pellet
the cells by centrifugation (5 min, 4006g, 4uC).
N Add 0.05 ml of appropriately diluted in ‘‘wash medium’’
secondary fluorescent (PE or FITC) anti-mouse antibody and
resuspend the cells by pipetting;
N Incubate the plate for 30 min at 4uC;
N Wash the cells once by adding 0.25 ml of medium and pellet
the cells by centrifugation (5 min, 4006g, 4uC).
N Add 0.05 ml of 1% paraformaldehyde solution to the cell
pellets, resuspend them by pipetting and leave for 5–10 min to
allow cell fixation and virus inactivation;
N Add 0.3 ml of PBS.
Day+1 12h00 (lunch break 12h00–14h00)
N At this stage, the cells could be kept for 1 or 2 days at 4uCi n
the dark prior to the flow cytometry analysis.
! Note that controls should include uninfected cells that have been treated
according to the abovementioned procedure!
Option 2 – for MV wild type strains. Perform cytometry 24 hours
post inoculation following the same steps as described in ‘‘option
1’’.
Option 3 – for MV GFP encoding viruses. Perform all the steps
described in ‘‘option 1’’ except primary and secondary antibody
labeling. After trypsinization, fix cells and perform the flow
cytometry analysis.
5. Flow cytometer acquisition (Day+1 14h00). Set the side
scatter (SSC) and the forward scatter (FSC) to select viable cells on
unlabeled cell sample. Adjust the fluorescence background of the
unlabeled cell sample to the lowest intensity (i.e. to have the
fluorescent histogram close to the ordinate). Set the fluorescent
threshold for positivity by gating more than 99.5% of the
uninfected control cells outside the gate. Analyze every virus
dilution by flow cytometry.
6. Titer calculation (End of the titration assay Day+1
16h00). First, determine the number of non-infected cells after
infection, and then calculate for each sample the number of non-
infected cells (N[n.i.]) within the 100 000 cell input according to
the following
Nn :i: ½  ~100,000
| 1{
%F z after infection{%F z without infection ðÞ
100{%F z without infection ðÞ

where F
+ cells are cells with fluorescence above the .99.5%
threshold defined above.
Example: For a threshold set to 0.3 %F
+ on the uninfected
control sample, and a percentage of infected cells %F
+=10.3% in
a test inoculated sample, then the number of non-infected after
virus inoculation is
Nn :i: ½  ~100,000| 1{
10:3{0:3 ðÞ
100{0:3 ðÞ

~89,969 cells
Calculate the titer from the number of uninfected cells: this titer
estimation is based on the fact that the probability P(n) that one
cell could be infected by ‘‘n’’ viral particles follows the Poisson law
of the parameter ‘‘l’’ which is equal to the multiplicity of infection
(MOI).
Pn ðÞ ~e{l:l
n=n!
The probability that one cell will not be infected is then equal to
P(0)=e
2l.
P(0) could be calculated experimentally by determining the
proportion of uninfected cells from the total number of cells:
P0 ðÞ ~ total number of cells-number of ð
infected cellsÞ=total number of cells
Consequently, the MOI (l)=2ln P(0).
Calculate the titer using the formula:
Titer Infectious Units=ml ðÞ ~{ln P 0 ðÞ |n=v
where P(0) is the fraction of uninfected cells (N[n.i.]/100 000), ‘‘n’’
is the number of cells in each well at the time of infection (i.e.
100 000) and ‘‘v’’ the undiluted virus input volume (in ml).
The Poisson’s law is valid provided that the total number of cells
is higher than 10, the number of infectious virus is higher than 30
and the MOI is below 10. While the two former parameters are
always respected because of the high cell number and minimal
virus input, MOI could be well over 10 for virus-rich samples.
When the percentage of infected cells exceeds 30–40% the titer
value tends to be underestimated. Thus, exclude values .40%
infected cells from the calculation Likewise, exclude values below
,0.5% infected cells since they fell too close to the background
limit to be taken into account. Average the titers calculated from
consecutive 3-fold dilution ranges showing ,3-fold intervals.
For automatic titer calculation, an online spreadsheet (csv file) is provided
where the results from the flow cytometry for all viral inputs are simply entered
where indicated. This file can be downloaded by following the link below
(Ctrl+click):
Rapid Method for Virus Titration
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VaUk1fMDktOXZYQnA3dUo4UEgwV3c&hl=en
You can also copy and paste the link into your browser.
Then, go to ‘‘File’’RdownloadRExcel
Materials
Cells: Vero -ATCC CCL-81; Vero-SLAM [15]; GHOST Cell
Transfectants - GHOST (3) CXCR4 (NIH AIDS reagent
program). Media and reagents: Dulbecco’s Modified Eagle medium
(DMEM); 0,05% Trypsine-EDTA; Phosphate Buffered Saline
pH 7.2–7.4; Fetal Calf Serum; Measles virus anti F monoclonal
antibody Y503 [16–17] (available upon request to D. Gerlier);
Goat F(ab9)2 Fragment Anti-Mouse IgG (H+L)-FITC – Beckman
Culter; Goat F(ab9)2 Fragment Anti-Mouse IgG (H+L)-PE –
Beckman Culter; Sodium azide, Sigma-Aldrich; Paraformalde-
hyde 95% Powder, Sigma-Aldrich. Plastics: Becton Dickinson
FalconH Multiwell
TM 48 well; Nunc
TM 96 well polystyrene, clear,
V-bottom plates, VWR; Becton FalconH 5 ml polystyrene round-
bottom tubes 12675 mm. Equipments: Flow cytometer; Refriger-
ating centrifuge for plates; Multichannel pipette (30–300 ml);
Pipetman (1–20 ml, 20–200 ml, 100–1000 ml); Pipetman tips (1–
200 and 100–1000 ml).
Results and Discussion
Comparison of the rapid method for MV titration with
TCID50
In order to validate the rapid protocol for measles virus titration,
we have compared it to the classical TCID50 method. The latter
was chosen instead of the PFU method since it is less laborious and
operator dependent, there are no plaque-counting difficulties [18],
and it has been routinely used by our laboratory over 20 years
after internal validation in agreement with a large-scale European
assessment [19] and WHO recommendations (http://www.who.int/
vaccines-documents/DocsPDF-IBI-e/mod7_e.pdf ). Six independent ti-
trations of a given viral stock of MV-Schwarz strain gave a similar
titer with 1% variation compared to 1.5% using the TCID50
titration method for the same sample. This demonstrates that the
flow cytometry-based titration method is reproducible. Further-
more, titers of near one hundred MV stocks measured by both
flow cytometry and TCID50 assay showed a high level of
correlation (Fig. 3, r=0.930, 2a,0.001).
After elaborating the novel titration assay, we defined its
detection limit. A series of 10-fold dilutions of an MV-Schwarz
strain stock (6.3 Log IU/ml) was used to evaluate the sensitivity of
the technique. To allow the increase of the inoculation volume and
to compensate for low viral concentration of some samples, 12-well
plates and 4610
5 cells were used. Virus concentration, smaller
than 4 Log IU/ml, could not be accurately measured by the flow
cytometry assay, even when using higher inoculation volumes than
0.3 ml in a final volume of 1 ml of growth medium.
Titration of MV strains
Wild type MV strains are routinely isolated from infected
patients by growing them exclusively on CD150/SLAM express-
ing cells. In the past, other MV strains have been isolated, passed
on Vero cells with acquisition of a tropism for CD46 due to only a
few point mutations in the H protein, the most prominent of which
is N481Y [20]. These strains are called ‘‘laboratory strains’’ (or
Edmonston-like). Some of them have been further attenuated by
forced growth in chicken embryonic fibroblasts to give rise to the
currently widely used measles vaccine strains. Wild type MV and
laboratory/vaccine strains are titrated using Vero-CD150/SLAM,
and Vero cells, respectively.
MV laboratory strains (MVHalle, recombinant MV-eGFP,
MV-Edmonson), MV vaccine strain (MV-Schwarz), and wild type
(MV-G954) virus stocks have been accurately quantified using the
rapid method for titration by exactly following the steps from the
procedure described in the ‘‘Materials and Methods’’ section
above. Examples of MV strains titrations are presented on
Figure 4. The titers obtained by the flow cytometry technique
were within the error range of those obtained by the TCID50
method.
The titration by flow cytometry measures only infectious
MV particles
Not all viruses produced by the target cells are infectious.
Indeed, a large proportion of the virus progeny is defective (non-
infectious), and could bind to, and possibly enter into, host cells.
Consequently, viral glycoproteins may be found at the cell surface
due to the fusion of the viral and cellular membranes leading to an
overestimation of the number of infected cells.
To rule out this hypothesis, the rapid titration method was
applied to an MV suspension inactivated by UV irradiation at
254 nm for 25 min. Twenty hours post infection and even at the
highest virus input (equivalent to MOI=10), no F protein labeling
was detected from the UV inactivated virus while the non-
irradiated control virus stock showed the expected titer value of
10
6 IU/ml (data not shown). Similar results were obtained when
MV was heated at 60uC for 20 min, a condition that abolishes
virus fusion but not virus binding to the cellular receptor [21]. This
indicates that defective virions are not taken into account in the
virus titration based on flow cytometry, likely because of the
internalization of the adsorbed viral glycoproteins in agreement
with the endocytosis of MV bound to its cellular receptor [22].
Thus, the flow cytometry based rapid method measures
infectious virus particles (viruses that can undergo at least one
complete infection cycle).
Figure 3. Correlation between titers obtained by the TCID50
technique and the rapid method for titration based on flow
cytometry. Ninety five viral stocks from MV strains were titrated by the
two techniques with highly correlated values (r=0,930, 2a,0.001).
doi:10.1371/journal.pone.0024135.g003
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single round of infection and can be used to determine
the duration of the virus replication cycle
The major pitfall that could compromise the accuracy of virus
titration by flow cytometry is the overestimation linked to data
poisoning by secondary infection. Indeed, during the assay,
infected cells progressively become producers of new virions that
may spread to cells that have initially escaped infection by the
inoculum. Therefore, it is essential to determine the optimal
interval separating the virus inoculation and the cell harvest for
flow cytometry analysis.
This interval could be experimentally determined by examining
the histograms of the distribution of MV-F expressing cells after
infection by various inoculum volumes over several time points. In
the case of MV-Halle strain, the flow cytometry analysis was
performed at 6, 18, 24 and 48 hours post infection (h.p.i.) (Fig. 5,
panel ‘‘A’’). The distribution of MV infected cells inoculated with
the largest volume (0.03 ml, green histogram) was already close to
100% at 6 h.p.i., but the expression level of F glycoprotein
continued to increase up to 18 h.p.i. to remain stable at later time
points. This could be interpreted as 18 hours being the time
required to reach the maximal expression of F glycoprotein at the
Figure 4. Titer calculation of different measles virus strains. (A) Calculation of MV-Halle titer based on flow cytometry detection of
MV-F protein. 3-fold serial dilutions of MV-Halle viral stock were used to infect Vero cells. The percentage of infected cells was determined at
18 h.p.i. by flow cytometry. As seen with the histogram, the peak of MV-F positive cells shifts towards the negative cells (left) gradually with the
decrease in viral volume used (left panel). The titers expressed as infectious units per milliliter (IU/ml) were calculated for each inoculum size as a
percentage of the uninfected cells, according to the Poisson Law (right panel). The values in red were used to calculate the average titer. (B)
Calculation of MV-Schwarz titer based on flow cytometry detection of MV-F protein. 3-fold dilutions of MV-Schwarz viral stock were used
to infect Vero cells. The percentage of infected cells was determined at 18 h.p.i. by flow cytometry (left panel). The titers expressed as infectious units
per milliliter (IU/ml) were calculated for each inoculum size as a percentage of the uninfected cells, according to the Poisson’s law (right panel). The
values in red were used to calculate the average titer. (C) Calculation of MV-eGFP titer based on the detection of GFP positive cells by flow
cytometry. 3-fold serial dilutions of MV-eGFP viral stock were used to infect Vero cells. The percentage of GFP expressing infected cells was
determined at 18 h.p.i. by flow cytometry (left panel). The titers expressed as infectious units per milliliter (IU/ml) were calculated for each inoculum
size as a percentage of the uninfected cells, according to the Poisson’s law (right panel). The values in red were used to calculate the average titer.
doi:10.1371/journal.pone.0024135.g004
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smaller inoculums, the histograms of infected cells were progres-
sively and regularly shifted to the left. This held true until 18 h.p.i.
At 24 h.p.i., the inoculation with the second largest volume
(0.010 ml) resulted in a peak shift that partially overlapped with
that observed with 0.030 ml (Fig. 5, compare pink and green
histograms). At the last time point studied (48 h.p.i.), histograms
from the first five virus inputs almost completely overlapped, and
even a very small inoculum (MOI as low as 10
24) gave rise to a
significant percentage of infected cells (black histogram). The time
interval allowing maximal expression of the viral gene with the
highest inoculum, but not allowing similar expression levels with a
lower inoculum size was thus considered to represent the duration
of a single virus replication.
For the wild type MV-G954 strain, the optimal incubation time
was slightly delayed to 24 h. (Fig. 5, panel ‘‘B’’).
To further confirm the above observations, two complementary
experiments using entry inhibitors for de novo produced virions
were carried out. First, we took advantage of a fusion inhibitory
peptide – FIP (z-D-Phe-L-Phe-L-Gly), which above 0.1 mg/ml
fully prevents MV entry (Fig. 6A, compare panel ‘‘c’’ with panel
‘‘a’’). FIP was added at 6 h.p.i. to block any secondary infection.
Histogram profiles of MV-Schwarz infected cells observed for each
inoculum size at 18 h.p.i. were very similar to the non-treated
cultures (Fig. 6, compare panel ‘‘b’’ with panel ‘‘a’’), thus
excluding any detectable contribution of secondary infection when
counting the number of infected cells at 18 h.p.i. Second, we
added a potent neutralizing antiserum at 6 h.p.i. to prevent
Figure 5. Defining the titration time for different viruses. MV-Halle (panel A), wt MV-G954 (panel B), and VSVeGFP (panel C) stocks were used
in 3-fold serial dilutions to infect Vero, Vero-SLAM and Vero cells, respectively. At different times post infection, cells were collected and analyzed by
flow cytometry to determine infected cells for each virus input. The optimal time for virus titration reflects the first overlap between the peaks of the
most concentrated dilution and the adjacent one and is marked with a ‘‘star’’ on the corresponding histogram. For each dilution, titers have been
calculated by applying the Poisson law, and values expressed in IU/ml as function of the inoculation volume (see the charts below the histogram
panel for each virus). The red curves reflect the time when a single replication cycle has occurred. The titer is determined by the average of the values
on the level curve (red) and is compared to the titer obtained by TCID50 technique below each chart.
doi:10.1371/journal.pone.0024135.g005
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almost completely abolished infection, the delayed addition of the
antiserum by 6 hours did not interfere with the virus titration
(Fig. 6). This strongly suggests that the time interval we have
graphically selected as described in Fig. 5 is close to a single virus
infection cycle and is optimal to quantify any given infectious virus
sample.
Thus, provided that the duration of infection allows only a
single cycle of virus replication, the rapid method for measles virus
titration is accurate.
Application for titration of VSV-gfp
The optimal time to titer another virus, VSV-gfp, was
determined as 8 h.p.i. (Fig. 5 panel ‘‘C’’), which fit well with the
6–8 hours duration of the VSV replication cycle [23],[24]. When
the apparent titers were blindly calculated for each inoculum and
for every time interval, their plotting against the inoculum size
gave rise to an almost perfect and expected horizontal distribution
(i.e. an identical titer value independent of inoculum size) only at
the optimal time for each virus (i.e. 18 h.p.i., 24 h.p.i. and 8 h.p.i.
red curves, bottom graphs). Finally, the titer, determined by the
rapid titration procedure at 8 h.p.i. correlated best with the titer
obtained by the classical TCID50 method.
Application for titration of HIV-1
The protocol was adapted to quantify HIV-1 using indicator
cells expressing a reporter gene product upon activation from an
incoming virus. GHOST HIV-1 indicator cells encode for a GFP
protein under the control of HIV-1 LTR and thus respond to Tat
protein expression resulting from an HIV-1 infection by becoming
Figure 6. Determination of the duration of a single virus replication cycle and the reading time for titration. (A) The rapid method
for MV titration is based on a single infection cycle. Vero cells were inoculated with MV-Halle strain for 6 hours. Then, they were washed with
PBS to eliminate residual virus. Medium supplemented or not with 0.1 mg/ml of the fusion inhibitory peptide (FIP) was then added. At 18 h.p.i., cells
were analyzed by flow cytometry and similar titers were found in both cases (i.e. with and without FIP) (Compare ‘‘a’’ 7.86 Log IU/ml and ‘‘b’’ 7.92 Log
IU/ml. As a control for FIP efficiency, its addition just before the virus inoculation completely prevented MV infection ‘‘c’’. (B) Validation of
estimated virus cycle duration as reading time for titration. Similar titers were obtained after inhibition of secondary infection by anti-
measles serum. Vero cells were infected with MV-eGFP for 6 hours, then washed with PBS and further incubated in the presence ‘‘a’’ or absence ‘‘b’’ of
a potent neutralizing antiserum. ‘‘c’’ - neutralization efficiency of the anti-serum upon addition to the virus inoculum prior to infection. Note for the
highest inoculum volume, a small GFP background signal was detected due to the low amount of GFP embarked into the input virus particles.
doi:10.1371/journal.pone.0024135.g006
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kinetics experiment was done over 72 hours. To overcome any
interference of cell number changes due to proliferation during the
titration assay, the experiment was duplicated in the presence of
aphidicolin, a reversible inhibitor of the DNA polymerase. Indeed,
after one day lag period, cells started to proliferate to double in
number within two days of infection (Fig. 7B) and stop growing
thereafter. The aphidicolin treatment prevented any increase in
cell number without affecting cell viability over the first 48 h.
Virus titration over a wide range of inoculation volumes was found
to be more reliable in the presence than in the absence of
aphidicolin (compare Fig. 7C with Fig. 7D online), and titers
determined after 48 h of culture were within the error range of
that determined by the TCID50 assay.
Application for titration of HIV-1 based lentivectors
Different virus inputs (10 ml,3 ml,1 ml,0.3 ml) from a concentrated
stock of HIV-1 based lentiviral particles (pseudotyped with VSV
envelope G protein and expressing GFP as a transgene [26–28]) were
used to infect Vero cells according to the procedure already described
above. 24 hours afterwards, the cells were trypsinized and GFP
positive cells were measured by flow cytometry. The titer was
calculated for each input, and values below 50% of F
+ cells were
averaged to calculate the titer. Example: for virus volumes 0.3 ml,
1 ml, 3 mla n d1 0ml the percentage of infected cells was 15.3%,
43.7%, 72.4% and 96.3%, respectively. Therefore the virus titer (as
average) was calculated from the 2 lowest flow cytometry values and
was 7.75 Log IU/ml (which corresponds to (7.74 Log IU/ml for
15.3%+7.76 Log IU/ml for 43.7%)/2=7.75).
Comparison with other available virus titration methods
In comparison with other flow-cytometry based methods
described previously to titer different viruses [3–13], our technique
appears original and complementary in several aspects: (i) a
complete set of critical parameters has been fully explored and
experimentally validated; (ii) our method is the first one to describe
a flow-cytometry based procedure to determine the duration of a
single virus replication cycle, a key parameter for titration
accuracy, and (iii) the first rapid method for quantifying different
measles virus strains; (iv) adjustments of critical parameters
allowed its use to titer two other unrelated viruses, VSV and
HIV-1; (v) by applying the Poisson law the titer calculation
appeared to be very precise and highly reproducible.
Compared to the PFU method and TCID50, the flow
cytometry based method has the advantage of being rapid which
might be crucial in vaccine production and when short deadlines
Figure 7. Calculation of HIV-1 NL4-3 titer using GFP expressing indicator cells. HIV-1 (NL4-3 strain) stock was titrated both by serial
dilutions in SupT1 cells and GHOST cells. End-point titration using the lymphocytic cell line SupT1 (data not shown) was based on the appearance of
syncytia and took up to 2 weeks. The GHOST indicator cells were used for HIV-1 titration by flow cytometry. These cells express the GFP protein under
the control of the HIV-1 LTR that can be activated by Tat from the incoming HIV-1 (A). GHOST cells seeded one hour before were infected with serial
3-fold dilutions of HIV-1 stock in the absence (C) or presence (D) of 1 mg/ml aphidicolin. At various times post-infection, cells were collected, fixed and
GFP expression analyzed by flow cytometry. In parallel, at every time point, the cells were collected from non-infected wells to count the cell number
for cell growth determination (B).
doi:10.1371/journal.pone.0024135.g007
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to titer non-replicative virus particles (e.g. lentiviral vectors), and a
large number of virus samples may be compared simultaneously
thanks to limited handling and high precision. However, there are
two major limitations: (i) the detection limit is 10
4 IU/ml, which
prevents its use for titration of clinical samples that often have a
low virus load, and (ii) it is not recommended for viruses (mutants,
etc.) with replication cycles exceeding more than 2 days.
Alternative methods have been designed based on the measure
of either the genome content of a viral suspension [12] or cell-
associated viral nucleic acids by quantitative real-time PCR after
end point dilution of the infecting virus (PCR infectivity assay)
[29–30]. However, the obtained viral nucleic acid values have to
be calibrated using an infectious virus reference, and any change
in the [nucleic acid/infectious unit] ratio prevents the accurate
determination of the number of infectious particles. The
advantages/disadvantages and specific required equipment of
every titration methods have been listed in Table 2 as a helpful
tool to choose the most suitable titration procedure.
Conclusion
The virus titration method based on the detection of infected
cells by flow cytometry after a time interval corresponding to one
virus replication cycle proved to be reproducible, accurate, rapid
(one virus replication length), and with a detection limit of 10
4 IU/
ml. Furthermore, it could be easily automated [31]. Titers
obtained through this technique correlate significantly with those
determined by the classical TCID50 method but with higher
accuracy and a 3-fold lower range of confidence limit. Such a
method may be particularly beneficial for studies requiring
titration of large numbers of MV stocks and especially when strict
deadlines should be respected. In principle this method can be
adapted to titer any virus for which a viral protein can be easily
detected by flow cytometry, including recombinant viruses
carrying a fluorescent reporter gene (or any gene encoding a cell
surface protein that could be immunolabelled) and the use of
indicator cells with an endogenous reporter gene that is inducible
upon virus infection (see Table 1 for setting up steps of a new virus
titration assay). The method is not suitable for titration of viruses
(e.g. recombinant viruses, mutants, etc.) which replication cycle
takes more than 30 h unless the cell proliferation is prevented.
Indeed, the accuracy of virus titration critically relies on the
precision of seeded cell number that is used in the formulae to
calculate the titer. Any significant cell growth during the assay may
result in the underestimation virus titer because infected cells
usually grow slower than uninfected cells. This method could
prove useful to titrate HIV and HIV molecular clones designed to
undergo a single viral cycle. Moreover, this method also allows
determination of the duration of a virus replication cycle, a key
parameter for the accuracy of the virus titration.
Table 1. Adaptation of the titration protocol for a given virus.
I Choice of cell line Use a highly permissive cell line on which the virus can be isolated and produced.
For lentiviral vectors pseudotyped with VSV G protein, chose the cell line that you most
commonly use for your experiments.
IIa Labelling: choice of the virus encoded marker
detectable by flow cytometry
For enveloped viruses: use cell surface glycoprotein if well expressed and good antibodies
are available.
For non-enveloped viruses: use intracellular immunolabelling against a structural viral
protein. In that case, a permeabilisation step prior antibody labelling is necessary.
For GFP expressing viruses: follow GFP expression.
For lentiviral vectors: use appropriate labelling against the transgene (if the transgene is
not a fluorescent protein).
IIb Labelling: optimization Optimized the immunolabelling conditions (antibody choice, saturating concentration of
immunoreagents, choice of permeabilization procedure that minimize non-specific labelling)
on cells infected at a MOI of 0.1 to 1.
III Determination of the duration of the virus
replication cycle
1. Perform infection kinetics using 3-fold dilutions of the virus stock for different time points
(i.e. 6 h, 8 h, 18 h, 24 h, 30 h, 36 h, and 48 h).
2. Calculate titres for each dilution used and plot them on a graph «titer/inoculation volume»
for each time point. The average titre obtained from all dilutions per time point should be
noted (preferably, MOIs between 0,5 and 0,02 should be considered).
3. Perform titration of your viral stock using an already described and validated method, i.e.
TCID50. Note the titre.
4. Define the single replication cycle by analyzing the flow cytometry histograms: note the
time point where the peak of the second virus input starts to approach and overlap the peak
of the first (highest) virus input)
5. Correlate the data from point 2, 3 and 4 above. The duration of the replication cycle should
correspond to the time point where the slope of the time course is close to 0. If more than
one similar slope is available, choose the one which gives the titre that correlates best with
the titre in TCID50.
6. Choose the length of the virus replication cycle as the infection duration for the titration
procedure.
IV Confirmation Check that the time interval define in III is correct by comparing the virus titres obtained in
the absence and in the presence of either an antibody (serum), or a virus entry inhibitors that
block secondary infection added few hours after the virus inoculation (see text for details).
V Exclude false positive signal Inactivate your virus by UV treatment and check if you still get labelling by flow cytometry. If
yes, virus titration by flow cytometry is not recommended.
VI Validation Perform multiple titration of the same viral stocks using an already accepted technique i.e.
TCID50/PFU and the novel method.
VII Detection limit Prepare 10-fold (or 5-fold) dilutions of your viral stock and titre each of them.
doi:10.1371/journal.pone.0024135.t001
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